Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor, Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT04806464
What this trial is testing

Clinical Study of VG161 in Subjects with Advanced Primary Liver Cancer

Who this might be right for
Primary Liver Cancer
CNBG-Virogin Biotech (Shanghai) Ltd. 44
Early research (Phase 1)Study completedNCT03625505
What this trial is testing

Assess Safety and Efficacy of Venetoclax in Combination With Gilteritinib in Participants With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 61
Testing effectiveness (Phase 2)Study completedNCT03560531
What this trial is testing

ZN-c5 in Subjects With Breast Cancer

Who this might be right for
Breast Cancer
Zeno Alpha Inc. 181
Testing effectiveness (Phase 2)Study completedNCT02273739
What this trial is testing

Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation

Who this might be right for
Solid TumorGliomaAngioimmunoblastic T-cell Lymphoma+2 more
Celgene 21
Early research (Phase 1)UnknownNCT04412577
What this trial is testing

TQB3473 Tablets in Subjects With Relapsed or Refractory Hematological Malignancies

Who this might be right for
Relapsed/Refractory Hematological Malignancies
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 57
Large-scale testing (Phase 3)Looking for participantsNCT07365241
What this trial is testing

Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
AbbVie 531
Early research (Phase 1)Study completedNCT03311477
What this trial is testing

Evaluate the Safety and Pharmacokinetics ABBV-399 in Japanese Participants With Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 9
Large-scale testing (Phase 3)Study completedNCT01001377
What this trial is testing

ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Amgen 1,010
Not applicableStudy completedNCT02209012
What this trial is testing

Twelve Month Follow-Up of CP0108

Who this might be right for
Actinic Keratosis
DUSA Pharmaceuticals, Inc. 206
Not applicableNot Yet RecruitingNCT07575854
What this trial is testing

Selective Internal Radiation Therapy for the Management of Chemotherapy-induced Thrombocytopenia With Splenomegaly in Adult Subjects With Gastrointestinal Cancer

Who this might be right for
Gastrointestinal Cancer
Centre Georges Francois Leclerc 18
Early research (Phase 1)Study completedNCT01260545
What this trial is testing

Study of CA-18C3 in Subjects With Advanced Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Janssen Research & Development, LLC 14
Large-scale testing (Phase 3)Active Not RecruitingNCT03937219
What this trial is testing

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Exelixis 855
Early research (Phase 1)Study completedNCT00978731
What this trial is testing

Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemic Study

Who this might be right for
Leukemia
Bristol-Myers Squibb 46
Large-scale testing (Phase 3)Ended earlyNCT04308395
What this trial is testing

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)

Who this might be right for
Basal Cell Nevus Syndrome
Sol-Gel Technologies, Ltd. 108
Testing effectiveness (Phase 2)Study completedNCT03303339
What this trial is testing

Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Cardiff Oncology 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07061639
What this trial is testing

QLS5133 Monotherapy in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd. 212
Early research (Phase 1)Study completedNCT02081495
What this trial is testing

DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer

Who this might be right for
Neoplasms
Janssen Research & Development, LLC 35
Testing effectiveness (Phase 2)WithdrawnNCT04995094
What this trial is testing

Study of Neoadjuvant Imprime PGG and Pembrolizumab for Stage III, Resectable Melanoma

Who this might be right for
Pathologic Stage III Cutaneous Melanoma AJCC v8
HiberCell, Inc.
Not applicableActive Not RecruitingNCT05981131
What this trial is testing

Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Non Muscle Invasive Bladder Cancer
ImmunityBio, Inc. 6
Not applicableLooking for participantsNCT03137095
What this trial is testing

Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI

Who this might be right for
Cancer Related Cognitive DifficultiesBreast Cancer Female
University of Rochester 150
Next Page